Last week, the US Food and Drug Administration announced a move to improve transparency and strengthen the safety of chemicals used in the nation's food supply.

Amid concerns about FDA’s capacity to meet safety mandates following the departure of 3,500 employee since January, the ...

New concerns are emerging over the safety of the nation’s baby formula supply and possible contaminants that aren’t fully ...

Commissioner Marty Makary said FDA employees are overseeing the use of AI, but questions remain about how the technology will be applied amid staff cuts.

The Consumer Brands Association argues the CPG industry has been ‘putting the transparency into ‘radical transparency’ for ...

FDA announced efforts to streamline its drug importation process to help U.S. states and Native American tribes access ...

Corporate influence The report claims that industry-funded research outpaces public funding, with the chemical industry ...

The amount of compensation paid to victims of drug side effects in South Korea declined in 2024 for the first time in six ...

Hearings were originally scheduled for this week on SB 2385 and HB 3350, which would stop drugmakers from cutting off steep ...

US FDA places clinical hold on Rocket Pharma's gene therapy phase 2 trial of RP-A501 to treat Danon disease: Cranbury, New Jersey Wednesday, May 28, 2025, 14:00 Hrs [IST] Rocket P ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Health Secretary Robert F. Kennedy Jr. upended decades of standard protocol in announcing that the vaccine would be dropped ...